Effect of sirolimus as an immunosuppressive agent on kidney transplantation in patients with diabetes mellitus; a systematic review
Introduction: Sirolimus is a macrolide and a type of immunosuppressant drug to prevent rejection of transplanted organs. This drug inhibits the activation of T and B lymphocytes and reduces the production of interleukin-2 (IL-2). Objectives: This study aimed to review the effect of sirolimus in kidn...
Main Authors: | Saeedeh Davar, Mohsen Mohammad Rahimi, Maasoumeh Mahdi Akhgar, Sajjad Saei |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Diabetic Nephropathy Prevention
2020-04-01
|
Series: | Journal of Nephropathology |
Subjects: | |
Online Access: | https://nephropathol.com/PDF/jnp-9-e13.pdf |
Similar Items
-
Favorable Results of Concomitant Tacrolimus and Sirolimus Therapy in Taiwanese Renal Transplant Recipients at 12 Months
by: Kuo-Hsin Chen, et al.
Published: (2008-07-01) -
Sirolimus-induced bronchiolitis obliterans organizing pneumonia in a kidney transplant recipient; a case report and review of literature
by: Behzad Einollahi, et al.
Published: (2014-07-01) -
The side effect profile of sirolimus and its relationship with some variables: A retrospective study of Iranian renal transplant patients
by: Shahrzad Shahidi, et al.
Published: (2023-01-01) -
Lymphedema attributed to sirolimus
by: Ardalan Mohammad-Reza
Published: (2013-04-01) -
De novo cancer avoidance after renal transplantation: A case–control study on low-dose sirolimus combined with a calcineurin inhibitor
by: Kuo-Hsin Chen, et al.
Published: (2015-06-01)